Citation: Jd. Sandy et C. Verscharen, Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo, BIOCHEM J, 358, 2001, pp. 615-626
Authors:
Sandy, JD
Westling, J
Kenagy, RD
Iruela-Arispe, ML
Verscharen, C
Rodriguez-Mazaneque, JC
Zimmermann, DR
Lemire, JM
Fischer, JW
Wight, TN
Clowes, AW
Citation: Jd. Sandy et al., Versican V1 proteolysis in human aorta in vivo occurs at the Glu(441)-Ala(442) bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4, J BIOL CHEM, 276(16), 2001, pp. 13372-13378
Authors:
Sandy, JD
Thompson, V
Doege, K
Verscharen, C
Citation: Jd. Sandy et al., The intermediates of aggrecanase-dependent cleavage of aggrecan in rat chondrosarcoma cells treated with interleukin-1, BIOCHEM J, 351, 2000, pp. 161-166
Authors:
Sandy, JD
Thompson, V
Verscharen, C
Gamett, D
Citation: Jd. Sandy et al., Chondrocyte-mediated catabolism of aggrecan: Evidence for a glycosylphosphatidylinositol-linked protein in the aggrecanase response to interleukin-1 or retinoic acid, ARCH BIOCH, 367(2), 1999, pp. 258-264